Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Alimentary Pharmacology & Therapeutics
|
February 9, 2017
Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development
T Hammer, S N Lophaven, K R Nielsen, et al.
Gut
|
January 21, 2006
Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004
T Jess, E V Loftus, W S Harmsen, et al.
Breast Cancer Research and Treatment
|
August 15, 2000
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age
C Rose, C Kamby, H T Mouridsen, et al.
Alimentary Pharmacology & Therapeutics
|
January 6, 2010
Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis
S Odes, H Vardi, M Friger, et al.
Alimentary Pharmacology & Therapeutics
|
September 14, 2012
eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn’s disease
N Pedersen, M Elkjaer, D Duricova, et al.
Alimentary Pharmacology & Therapeutics
|
February 3, 2009
Infliximab dependency in children with Crohn's disease
D Duricova, N Pedersen, M Lenicek, et al.
Alimentary Pharmacology & Therapeutics
|
November 25, 2005
Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids
A A Nielsen, L G M Jørgensen, J N Nielsen, et al.
Alimentary Pharmacology & Therapeutics
|
August 6, 2011
Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006
A Bortoli, N Pedersen, D Duricova, et al.
Alimentary Pharmacology & Therapeutics
|
May 15, 2015
Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD
C Casén, H C Vebø, M Sekelja, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort
P Politi, P Bodini, M G Mortilla, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Alimentary Pharmacology & Therapeutics
|
February 9, 2017
Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development
T Hammer, S N Lophaven, K R Nielsen, et al.
Gut
|
January 21, 2006
Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004
T Jess, E V Loftus, W S Harmsen, et al.
Breast Cancer Research and Treatment
|
August 15, 2000
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age
C Rose, C Kamby, H T Mouridsen, et al.
Alimentary Pharmacology & Therapeutics
|
January 6, 2010
Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis
S Odes, H Vardi, M Friger, et al.
Alimentary Pharmacology & Therapeutics
|
September 14, 2012
eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn’s disease
N Pedersen, M Elkjaer, D Duricova, et al.
Alimentary Pharmacology & Therapeutics
|
February 3, 2009
Infliximab dependency in children with Crohn's disease
D Duricova, N Pedersen, M Lenicek, et al.
Alimentary Pharmacology & Therapeutics
|
November 25, 2005
Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids
A A Nielsen, L G M Jørgensen, J N Nielsen, et al.
Alimentary Pharmacology & Therapeutics
|
August 6, 2011
Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006
A Bortoli, N Pedersen, D Duricova, et al.
Alimentary Pharmacology & Therapeutics
|
May 15, 2015
Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD
C Casén, H C Vebø, M Sekelja, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort
P Politi, P Bodini, M G Mortilla, et al.
Page
of 7